223 related articles for article (PubMed ID: 16084128)
21. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging.
Deroose CM; Reumers V; Gijsbers R; Bormans G; Debyser Z; Mortelmans L; Baekelandt V
Mol Ther; 2006 Sep; 14(3):423-31. PubMed ID: 16820324
[TBL] [Abstract][Full Text] [Related]
23. A comparative analysis of constitutive and cell-specific promoters in the adult mouse hippocampus using lentivirus vector-mediated gene transfer.
Kuroda H; Kutner RH; Bazan NG; Reiser J
J Gene Med; 2008 Nov; 10(11):1163-75. PubMed ID: 18773500
[TBL] [Abstract][Full Text] [Related]
24. Fetal gene transfer with lentiviral vectors: long-term in vivo follow-up evaluation in a rat model.
Toelen J; Deroose CM; Gijsbers R; Reumers V; Sbragia LN; Vets S; Chitneni SK; Bormans G; Mortelmans L; Deprest JA; Debyser Z
Am J Obstet Gynecol; 2007 Apr; 196(4):352.e1-6. PubMed ID: 17403419
[TBL] [Abstract][Full Text] [Related]
25. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
Frecha C; Toscano MG; Costa C; Saez-Lara MJ; Cosset FL; Verhoeyen E; Martin F
Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
[TBL] [Abstract][Full Text] [Related]
26. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
27. Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome.
Mantovani J; Charrier S; Eckenberg R; Saurin W; Danos O; Perea J; Galy A
J Gene Med; 2009 Aug; 11(8):645-54. PubMed ID: 19455589
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral vector-mediated gene delivery into human embryonic stem cells.
Gropp M; Reubinoff B
Methods Enzymol; 2006; 420():64-81. PubMed ID: 17161694
[TBL] [Abstract][Full Text] [Related]
29. [Lentiviral vectors].
Spirin PV; Vil'gelm AE; Prasolov VS
Mol Biol (Mosk); 2008; 42(5):913-26. PubMed ID: 18988539
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral vectors: turning a deadly foe into a therapeutic agent.
Trono D
Gene Ther; 2000 Jan; 7(1):20-3. PubMed ID: 10680011
[TBL] [Abstract][Full Text] [Related]
31. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer.
Ogura T; Mizukami H; Mimuro J; Madoiwa S; Okada T; Matsushita T; Urabe M; Kume A; Hamada H; Yoshikawa H; Sakata Y; Ozawa K
J Gene Med; 2006 Aug; 8(8):990-7. PubMed ID: 16685745
[TBL] [Abstract][Full Text] [Related]
32. Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells.
Chen H; Yao H; Huang L; Shen Q; Jia W; Xue J
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1196-201. PubMed ID: 17184501
[TBL] [Abstract][Full Text] [Related]
33. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero.
Chen XG; Zhu HZ; Gong JL; Li F; Xue JL
Acta Pharmacol Sin; 2004 Jun; 25(6):789-93. PubMed ID: 15169633
[TBL] [Abstract][Full Text] [Related]
34. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.
Delgado M; Toscano MG; Benabdellah K; Cobo M; O'Valle F; Gonzalez-Rey E; MartÃn F
Arthritis Rheum; 2008 Apr; 58(4):1026-37. PubMed ID: 18383372
[TBL] [Abstract][Full Text] [Related]
35. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
36. DNA transposons for modification of human primary T lymphocytes.
Huang X; Wilber A; McIvor RS; Zhou X
Methods Mol Biol; 2009; 506():115-26. PubMed ID: 19110623
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks.
Weber E; Anderson WF; Kasahara N
Curr Opin Mol Ther; 2001 Oct; 3(5):439-53. PubMed ID: 11699888
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
39. Lentiviral vectors: are they the future of animal transgenesis?
Park F
Physiol Genomics; 2007 Oct; 31(2):159-73. PubMed ID: 17684037
[TBL] [Abstract][Full Text] [Related]
40. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.
Okada Y; Ueshin Y; Hasuwa H; Takumi K; Okabe M; Ikawa M
Genesis; 2009 Apr; 47(4):217-23. PubMed ID: 19208434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
